Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
abstract
Remarks:
article is in Japanese- abstract only in English

Data source

Reference
Reference Type:
publication
Title:
52-week oral toxicity study of lactitol (NS-4) in rats followed by 9-week recovery test
Author:
Okazaki S, Kobayashi J, Tamura K, Nagatani M, Hamasu Y, and Sumi N
Year:
1994
Bibliographic source:
J Toxicol Sci., 19(Suppl 3):377-404

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Results of a 52-week oral toxicity study followed by a 9-week recovery in rats was reported.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
4-O-β-D-galactopyranosyl-D-glucitol
EC Number:
209-566-5
EC Name:
4-O-β-D-galactopyranosyl-D-glucitol
Cas Number:
585-86-4
Molecular formula:
C12H24O11
IUPAC Name:
4-O-beta-D-galactopyranosyl-D-glucitol

Test animals

Species:
rat
Strain:
other: Slc:SD
Sex:
male/female

Administration / exposure

Route of administration:
oral: unspecified
Duration of treatment / exposure:
52 weeks with 9-week recovery
Doses / concentrationsopen allclose all
Dose / conc.:
400 other: mg/kg/day
Dose / conc.:
2 000 other: mg/kg/day
Dose / conc.:
10 000 other: mg/kg/day
No. of animals per sex per dose:
25
Control animals:
yes

Results and discussion

Results of examinations

Details on results:
Treatment related death, soft stool, diarrhea, decreased body weight and food intake, and increased water consumption were observed in the 10 g/kg group. Urinalysis showed increased Ca excretion in the 2 and 10 g/kg groups. In the 10 g/kg group, there was increased Ca++ excretion and urine specific gravity and decreased K+ and Na+ excretion and urine volume. Hematologic examination showed decreased platelet count in the 10 g/kg group. Biochemical examination revealed higher A/G ratio in the 2 and 10 g/kg groups. In the 10 g/kg group, there were lowered level of total cholesterol, triglyceride, phospholipid, Na+, Cl- and total protein. Distention of the cecum with increased organ weight was seen pathologically in the 2 and 10 g/kg groups. In the 10 g/kg group, caecal mucosa was hyperplasic. The adrenal gland was hypertrophic in the zona glomerulosa in the 2 and 10 g/kg groups. In the 10 g/kg group, the adrenal weight was increased. Dilatation of renal tubules was also found in the 10 g/kg group. The above mentioned changes satisfactorily reversible except for the increased cecum weight in the 10 g/kg group.

Effect levels

Dose descriptor:
NOAEL
Effect level:
>= 0.4 other: g/kg/day
Sex:
male/female
Basis for effect level:
body weight and weight gain
clinical biochemistry
food consumption and compound intake
gross pathology
histopathology: non-neoplastic
mortality
organ weights and organ / body weight ratios
urinalysis

Applicant's summary and conclusion

Conclusions:
A 52-Week rat oral study with a 9-week recovery with dosages of 0, 0.4, 2, and 10 g/kg/day of the test substance had a NOAEL of 0.4 g/kg/day.
Executive summary:

Twenty-five male and 25 female Slc:SD rats were given lactitol orally for 52 weeks at dosages of 0, 0.4, 2 and 10 g/kg/day. A 9 week recovery test was conducted after the discontinuation of the drug treatment. Treatment related death, soft stool, diarrhea, decreased body weight and food intake, and increased water consumption were observed in the 10 g/kg group. Urinalysis showed increased Ca excretion in the 2 and 10 g/kg groups. In the 10 g/kg group, there was increased Ca++ excretion and urine specific gravity and decreased K+ and Na+ excretion and urine volume. Hematologic examination showed decreased platelet count in the 10 g/kg group. Biochemical examination revealed higher A/G ratio in the 2 and 10 g/kg groups. In the 10 g/kg group, there were lowered level of total cholesterol, triglyceride, phospholipid, Na+, Cl- and total protein. Distention of the cecum with increased organ weight was seen pathologically in the 2 and 10 g/kg groups. In the 10 g/kg group, cecal mucosa was hyperplasic. The adrenal gland was hypertrophic in the zona glomerulosa in the 2 and 10 g/kg groups. In the 10 g/kg group, the adrenal weight was increased. Dilatation of renal tubules was also found in the 10 g/kg group. The above mentioned changes satisfactorily reversible except for the increased cecum weight in the 10 g/kg group. Based on the results obtained, the NOAEL of this study was 0.4 g/kg/day.